Search

everythinglearnresearchcommunity

for

Search:↓

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Stress increases neurosteroids that help prevent seizures.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Depressed teens have different steroid levels in urine, which may help identify and treat them.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.